BMP Pharma Trading AG (BST:BMP)
Germany
· Delayed Price · Currency is EUR 5.10
0.00 (0.00%)
At close: Mar 4, 2026
BMP Pharma Trading AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Revenue Growth (YoY) | -52.11% | 2764.29% | -96.58% | -63.16% | 345.20% | - | Upgrade
|
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Gross Profit | 0 | 0 | 0 | -0 | 0 | - | Upgrade
|
| Selling, General & Admin | 1.56 | 1.7 | 1.64 | 1.12 | 0.68 | 0.59 | Upgrade
|
| Other Operating Expenses | 0.21 | 0.21 | 0.21 | 0.06 | 0.12 | 0.1 | Upgrade
|
| Operating Expenses | 1.77 | 1.91 | 1.85 | 1.18 | 0.8 | 0.7 | Upgrade
|
| Operating Income | -1.77 | -1.91 | -1.85 | -1.18 | -0.8 | -0.7 | Upgrade
|
| Interest Expense | -0.01 | -0 | -0.01 | -0.01 | -0.01 | -0 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | 0 | - | -0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.23 | 6.09 | 5.93 | 3.4 | 4.02 | 0.99 | Upgrade
|
| Pretax Income | 4.47 | 4.19 | 4.09 | 2.22 | 3.21 | 0.3 | Upgrade
|
| Income Tax Expense | 1.39 | 1.31 | 1.34 | 0.65 | 0.59 | 0.13 | Upgrade
|
| Net Income | 3.08 | 2.88 | 2.75 | 1.57 | 2.62 | 0.17 | Upgrade
|
| Net Income to Common | 3.08 | 2.88 | 2.75 | 1.57 | 2.62 | 0.17 | Upgrade
|
| Net Income Growth | 3.77% | 4.59% | 75.39% | -40.06% | 1440.37% | -44.98% | Upgrade
|
| Shares Outstanding (Basic) | - | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | - | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| EPS (Basic) | - | 0.55 | 0.52 | 0.30 | 0.50 | 0.03 | Upgrade
|
| EPS (Diluted) | - | 0.55 | 0.52 | 0.30 | 0.50 | 0.03 | Upgrade
|
| EPS Growth | - | 4.59% | 75.39% | -40.06% | 1440.42% | -44.98% | Upgrade
|
| Dividend Per Share | 0.480 | 0.480 | 0.500 | - | - | - | Upgrade
|
| Dividend Growth | -4.00% | -4.00% | - | - | - | - | Upgrade
|
| Gross Margin | 38.99% | 14.28% | 39.29% | -46.28% | 12.29% | - | Upgrade
|
| Operating Margin | -222878.99% | -118988.15% | -3301448.21% | -72055.67% | -17878.21% | -69600.00% | Upgrade
|
| Profit Margin | 387862.77% | 179523.63% | 4916214.29% | 95712.07% | 58819.29% | 17000.00% | Upgrade
|
| EBITDA | - | - | -1.85 | - | -0.8 | - | Upgrade
|
| D&A For EBITDA | - | - | 0 | - | 0 | - | Upgrade
|
| EBIT | -1.77 | -1.91 | -1.85 | -1.18 | -0.8 | -0.7 | Upgrade
|
| Effective Tax Rate | 31.02% | 31.31% | 32.70% | 29.30% | 18.45% | 42.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.